SEC Info - FSD Pharma Inc. - ‘6-K’ for 11/6/23

SEC Info℠

Home

Help

Please Sign In

FSD Pharma Inc. – ‘6-K’ for 11/6/23

On: Tuesday, 11/7/23, at 10:30am ET · For: 11/6/23 · Accession #: 1654954-23-13848 · File #: 1-39152

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/07/23  FSD Pharma Inc.                   6-K        11/06/23    4:83K                                    Blueprint/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML     13K 
                Issuer                                                           
 2: EX-99.1     News Release                                        HTML     14K 
 3: EX-99.2     News Release                                        HTML     14K 
 4: EX-99.3     News Release                                        HTML     16K

‘6-K’ — Current, Quarterly or Annual Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________________

FORM 6-K

________________________________________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2023

Commission File Number: 001-39152

________________________________________________________

FSD PHARMA INC.

(Registrant)

________________________________________________________

199 Bay St., Suite 4000

Toronto, Ontario M5L 1A9 Canada

(Address of Principal Executive Offices)

________________________________________________________

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	FSD PHARMA INC.
	(Registrant)

Date November 6, 2023	By	/s/ *Nathan Coyle*
		Nathan Coyle
		Chief Financial Officer

EXHIBIT INDEX

Exhibit		Description of Exhibit

99.1		News Release dated September 18, 2023 – FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis. The Report Shows Compound to be Safe and Well Tolerated

99.2		News Release dated October 4, 2023 – FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice

99.3		News Release dated October 5, 2023 – FSD Pharma and Celly NU Enter into Arrangement Agreement

Dates Referenced Herein and Documents Incorporated by Reference

This ‘6-K’ Filing	Date	Other Filings

Filed on:	11/7/23	6-K
For Period end:	11/6/23	6-K
		List all Filings

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  FSD Pharma Inc.                   424B5       2/16/24    1:863K                                   RDG Filings/FA
12/26/23  FSD Pharma Inc.                   F-3        12/22/23    5:33M                                    Blueprint/FA

↑Top

Filing Submission 0001654954-23-013848 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

FSD Pharma Inc. – ‘6-K’ for 11/6/23

On: Tuesday, 11/7/23, at 10:30am ET · For: 11/6/23 · Accession #: 1654954-23-13848 · File #: 1-39152

Previous ‘6-K’: ‘6-K’ on 11/7/23 for 11/6/23 · Next: ‘6-K’ on / for 11/7/23 · Latest: ‘6-K’ on 5/7/24 for 5/6/24 · 2 References: By: FSD Pharma Inc. – ‘424B5’ on 2/20/24 By: FSD Pharma Inc. – ‘F-3’ on 12/26/23

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34Filing Table of Contents

‘6-K’ — Current, Quarterly or Annual Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

2 Subsequent Filings that Reference this Filing

Previous ‘6-K’: ‘6-K’ on 11/7/23 for 11/6/23 · Next: ‘6-K’ on / for 11/7/23 · Latest: ‘6-K’ on 5/7/24 for 5/6/24 · 2 References:

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents